Gergen Mark J — SEC Form 4 filings
SEC reporting owner CIK 1373110. 6 Form 4 filings on record with FilingPulse; latest filed 2025-01-08.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-02 to 2025-01-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 60,000 shares, $561,966 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 30,000 shares @ $9.46 ($283,866) in Poseida Therapeutics, Inc., filed 2024-12-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. (PSTX) | President and CEO, Director | 6 | — | 2 legs · 60,000 sh · $561,966 | 15 |
Form 4 filings — Gergen Mark J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-08 | 4 | Poseida Therapeutics, Inc. (PSTX) | Code (U): 636,726 · Disposition to issuer (D): 240,721 (derivative) @ $0 · Disposition to issuer (D): 48,115 (derivative) @ $0 · Disposition to issuer (D): 75,000 (derivative) @ $0 · Disposition to issuer (D): 342,000 (derivative) @ $0 · Disposition to issuer (D): 518,500 (derivative) @ $0 · +2 more | EDGAR |
| 2025-01-03 | 4 | Poseida Therapeutics, Inc. (PSTX) | Tax withholding (F): 23,313 @ $9.60 | EDGAR |
| 2024-12-11 | 4 | Poseida Therapeutics, Inc. (PSTX) | Option exercise (M): 30,000 @ $2.78 · Sale (S): 30,000 @ $9.46 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Poseida Therapeutics, Inc. (PSTX) | Option exercise (M): 30,000 @ $2.78 · Sale (S): 30,000 @ $9.27 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Poseida Therapeutics, Inc. (PSTX) | Tax withholding (F): 34,157 @ $4.13 | EDGAR |
| 2024-02-02 | 4 | Poseida Therapeutics, Inc. (PSTX) | Tax withholding (F): 47,162 @ $3.41 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1373110 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →